Misoprostol for labor induction in women with term premature rupture of membranes: A meta-analysis

Obstetrics and Gynecology

Volumn 106, Issue 3, 2005, Pages 593-601

  Lin, Monique G ^a,b   Nuthalapaty, Francis S ^a   Carver, Alissa R ^a   Case, Ashley S ^a   Ramsey, Patrick S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Division of Maternal Fetal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN; PLACEBO; PROSTAGLANDIN E2;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PREGNANCY; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMACH ULCER; SYSTEMATIC REVIEW; UTERINE CERVIX RIPENING; UTERUS CONTRACTION; VAGINAL DELIVERY;

EID: 23944486678     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000172425.56840.57     Document Type: Review

References (39)

1. Gunn GC, Mishell DR Jr, Morton DG. Premature rupture of fetal membranes: a review. Am J Obstet Gynecol 1970;106:469-83.
2. Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. N Engl J Med 1996;334:1005-10.
3. Lanier LR Jr, Scarbrough RW Jr, Fillingim DW, Baker RE Jr. Incidence of maternal and fetal complications associated with rupture of membranes before onset of labor. Am J Obstet Gynecol 1965;93:398-404.
4. Kappy KA, Cetrulo CL, Knuppel RA, Ingardia CJ, Sbarra AJ, Scerbo JC, et al. Premature rupture of membranes at term: a comparison of induced and spontaneous labors. J Reprod Med 1982;27:29-33.
5. Keirse MJ. Prostaglandins in preinduction cervical ripening: meta-analysis of worldwide clinical experience. J Reprod Med 1993;38 suppl:89-100.
6. Ekman-Ordeberg G, Uldbjerg N, Ulmsten U. Comparison of intravenous oxytocin and vaginal prostaglandin E2 gel in women with unripe cervixes and premature rupture of the membranes. Obstet Gynecol 1985;66:307-10.
7. Granstrom L, Ekman G, Ulmsten U. Cervical priming and labor induction with vaginal application of 3 mg PGE2 in suppositories in term pregnant women with premature rupture of amniotic membranes and unfavorable cervix. Acta Obstet Gynecol Scand 1987;66:429-31.
8. Goeschen K. Premature rupture of membranes near term: induction of labor with endocervical prostaglandin E2 gel or intravenous oxytocin. Am J Perinatol 1989;6:181-4.
9. Magos AL, Noble MC, Wong Ten Yuen A, Rodeck CH. Controlled study comparing vaginal prostaglandin E2 pessaries with intravenous oxytocin for the stimulation of labour after spontaneous rupture of the membranes. Br J Obstet Gynaecol 1983;90:726-31.
10. American College of Obstetricians and Gynecologists. Induction of labor. ACOG Practice Bulletin 10. Washington, DC: ACOG; 1999.
11. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001;344:38-47.
12. Ramsey PS, Harris DY, Ogburn PL Jr, Heise RH, Magtibay PM, Ramin KD. Comparative efficacy and cost of prostaglandin analogs dinoprostone and misoprostol as labor preinduction agents. Am J Obstet Gynecol 2003;188:560-5.
13. Ramsey PS, Ramin KD, Ramin SM. Labor induction. Curr Opin Obstet Gynecol 2000;12:463-73.
14. Wing DA. Labor induction with misoprostol. Am J Obstet Gynecol 1999;181:339-45.
15. Al-Hussaini TK, Abdel-Aal SA, Youssef MA. Oral misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term. Int J Gynaecol Obstet 2003;82:73-5.
16. Butt KD, Bennett KA, Crane JM, Hutchens D, Young DC. Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstet Gynecol 1999;94:994-9.
17. Crane JM, Delaney T, Hutchens D. Oral misoprostol for premature rupture of membranes at term. Am J Obstet Gynecol 2003;189:720-4.
18. Frohn WE, Simmons S, Carlan SJ. Prostaglandin E2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks. Obstet Gynecol 2002; 99:206-10.
19. Hoffman RA, Anthony J, Fawcus JA. Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term. Int J Obstet Gynaecol 2001;72:215-21.
20. Lo JY, Alexander JM, McIntire DD, Leveno KJ. Ruptured membranes at term: randomized, double-blind trial of oral misoprostol for labor induction. Obstet Gynecol 2003;101:685-9.
21. Morgan Ortiz F, Baez Barraza J, Quevedo Castro E, Cuetos Martinez CB, Osuna Ramirez I. Misoprostol and oxytocin for induction of cervical ripening and labor in patients with term pregnancy and premature membrane rupture [in Spanish]. Ginecol Obstet Mex 2002;70:469-76.
22. Mozurkewich E, Horrocks J, Daley S, Von Oeyen P, Halvorson M, Johnson M, et al. The MisoPROM study: a multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term. Am J Obstet Gynecol 2003;189:1026-30.
23. Ngai SW, Chan YM, Lam SW, Lao TT. Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. BJOG 2000;107:222-7.
24. Ngai SW, To WK, Lao T, Ho PC. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term. Obstet Gynecol 1996;87:923-6.
25. Ozden S, Delikara MN, Avci A, Fiçicioglu C. Intravaginal misoprostol vs. expectant management in premature rupture of membranes with low Bishop scores at term. Int J Gynaecol Obstet 2002;77:109-15.
26. Sanchez-Ramos L, Chen AH, Kaunitz AM, Gaudier FL, Delke I. Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study. Obstet Gynecol 1997;89:909-12.
27. Shetty A, Stewart K, Stewart G, Rice P, Danielian P, Templeton A. Active management of term prelabour rupture of membranes with oral misoprostol. BJOG 2002;109:1354-8.
28. Wing DA, Paul RH. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation. Am J Obstet Gynecol 1998;179:94-9.
29. Ayad IA. Vaginal misoprostol in managing premature rupture of membranes. East Mediterr Health J 2002;8:515-20.
30. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354: 1896-900.
31. Peipert JF, Bracken MB. Systematic reviews of medical evidence: the use of meta-analysis in obstetrics and gynecology. Obstet Gynecol 1997;89:628-33.
32. Alfirevic Z. Oral misoprostol for induction of labour (Cochrane Review): In: The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
33. Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour (Cochrane Review). In: The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
34. Danielsson KG, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999;93:275-80.
35. Khan RU, El-Refaey H, Sharma S, Sooranna D, Stafford M. Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstet Gynecol 2004;103:866-70.
36. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332-6.
37. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
38. Sanchez-Ramos L, Kaunitz AM, Delke I. Labor induction with 25 microg versus 50 microg intravaginal misoprostol: a systematic review. Obstet Gynecol 2002;99:145-5
39. Wing DA. A benefit-risk assessment of misoprostol for cervical ripening and labour induction. Drug Saf 2002;25:665-76.